UAS
XBI icon

United Asset Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

United Asset Strategies’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,129
Closed -$771K – 246
2024
Q1 		$771K Buy
+8,129
New +$754K 0.08% 168
2023
Q4 		– Sell
-2,796
Closed -$204K – 254
2023
Q3 		$204K Buy
+2,796
New +$223K 0.03% 219
2022
Q1 		– Sell
-3,409
Closed -$382K – 241
2021
Q4 		$382K Sell
3,409
-3,198
-48% -$386K 0.05% 168
2021
Q3 		$831K Buy
6,607
+440
+7% +$56.7K 0.11% 128
2021
Q2 		$835K Sell
6,167
-230
-4% -$30.2K 0.11% 126
2021
Q1 		$868K Sell
6,397
-2,347
-27% -$351K 0.13% 117
2020
Q4 		$1.23M Buy
8,744
+1,056
+14% +$135K 0.19% 92
2020
Q3 		$857K Sell
7,688
-1,690
-18% -$189K 0.16% 102
2020
Q2 		$1.05M Sell
9,378
-165
-2% -$16.3K 0.21% 90
2020
Q1 		$739K Sell
9,543
-2,205
-19% -$195K 0.18% 100
2019
Q4 		$1.12M Buy
11,748
+960
+9% +$83K 0.22% 98
2019
Q3 		$823K Buy
10,788
+315
+3% +$26.2K 0.18% 104
2019
Q2 		$919K Sell
10,473
-165
-2% -$14.1K 0.21% 100
2019
Q1 		$963K Sell
10,638
-70
-0.7% -$5.96K 0.23% 101
2018
Q4 		$768K Sell
10,708
-425
-4% -$34.2K 0.21% 101
2018
Q3 		$1.07M Sell
11,133
-144
-1% -$14K 0.25% 94
2018
Q2 		$1.07M Sell
11,277
-420
-4% -$38.6K 0.28% 89
2018
Q1 		$1.03M Sell
11,697
-1,534
-12% -$140K 0.3% 86
2017
Q4 		$1.12M Buy
+13,231
New +$1.11M 0.3% 81
2017
Q3 		– Sell
-18,561
Closed -$1.43M – 172
2017
Q2 		$1.43M Sell
18,561
-43,810
-70% -$3.11M 0.43% 64
2017
Q1 		$4.33M Buy
+62,371
New +$4.19M 1.32% 29

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

United Asset Strategies's XBI Position: Q2 2024 in Review

United Asset Strategies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 8,129 shares — an estimated $771K sold.

United Asset Strategies first reported a position in XBI in Q1 2017 and held it in 21 quarters. The position peaked at $4.33M in Q1 2017. 762 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • United Asset Strategies reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • United Asset Strategies sold 8,129 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $771K.
  • United Asset Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 21 quarters.
  • United Asset Strategies's State Street SPDR S&P Biotech ETF position peaked at $4.33M in Q1 2017.
  • 762 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on United Asset Strategies's 13F filing for Q2 2024, filed 1 Aug 2024.